125 related articles for article (PubMed ID: 34510841)
1. Expression of selected molecular factors in two types of endometrial cancer.
Markowska A; Gryboś A; Marszałek A; Bednarek W; Filas V; Gryboś M; Markowska J; Mądry R; Więckowska B; Nowalińska D; Szarszewska M
Adv Clin Exp Med; 2021 Oct; 30(10):1057-1064. PubMed ID: 34510841
[TBL] [Abstract][Full Text] [Related]
2. Studies on selected molecular factors in endometrial cancers.
Markowska A; Szarszewska M; Żurawski J; Sajdak S; Knapp P; Gryboś A; Olejek A; Bednarek W; Roszak A; Jóźwik M; Marszałek A; Filas V; Wójcik-Krowiranda K; Mądry R; Markowska J; Sozański R
Adv Clin Exp Med; 2018 Oct; 27(10):1417-1424. PubMed ID: 30277666
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biology.
Jarzabek K; Koda M; Walentowicz-Sadlecka M; Grabiec M; Laudanski P; Wolczynski S
Tumour Biol; 2013 Dec; 34(6):4007-16. PubMed ID: 23873111
[TBL] [Abstract][Full Text] [Related]
4. L1CAM as a Negative Prognostic Factor in Endometrioid Endometrial Adenocarcinoma FIGO Stage IA-IB.
Klat J; Mladenka A; Dvorackova J; Bajsova S; Simetka O
Anticancer Res; 2019 Jan; 39(1):421-424. PubMed ID: 30591489
[TBL] [Abstract][Full Text] [Related]
5. Functional oestrogen receptor α imaging in endometrial carcinoma using 16α-[¹⁸F]fluoro-17β-oestradiol PET.
Tsujikawa T; Yoshida Y; Kiyono Y; Kurokawa T; Kudo T; Fujibayashi Y; Kotsuji F; Okazawa H
Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):37-45. PubMed ID: 20717823
[TBL] [Abstract][Full Text] [Related]
6. Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study.
Capriglione S; Plotti F; Miranda A; Ricciardi R; Scaletta G; Aloisi A; Guzzo F; Montera R; Angioli R
Tumour Biol; 2015 Jun; 36(6):4151-6. PubMed ID: 25577252
[TBL] [Abstract][Full Text] [Related]
7. L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.
Zeimet AG; Reimer D; Huszar M; Winterhoff B; Puistola U; Azim SA; Müller-Holzner E; Ben-Arie A; van Kempen LC; Petru E; Jahn S; Geels YP; Massuger LF; Amant F; Polterauer S; Lappi-Blanco E; Bulten J; Meuter A; Tanouye S; Oppelt P; Stroh-Weigert M; Reinthaller A; Mariani A; Hackl W; Netzer M; Schirmer U; Vergote I; Altevogt P; Marth C; Fogel M
J Natl Cancer Inst; 2013 Aug; 105(15):1142-50. PubMed ID: 23781004
[TBL] [Abstract][Full Text] [Related]
8. Uterine endometrial carcinoma: 10 years' experience with long-term follow-up at a single Korean institution.
Lee EJ; Kim TJ; Choi CH; Lee JW; Lee JH; Bae DS; Park HM; Kim BG
Gynecol Obstet Invest; 2012; 74(4):313-9. PubMed ID: 23075517
[TBL] [Abstract][Full Text] [Related]
9. The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered?
Abu-Rustum NR; Zhou Q; Iasonos A; Alektiar KM; Leitao MM; Chi DS; Sonoda Y; Soslow R; Hensley M; Barakat RR
Int J Gynecol Cancer; 2011 Apr; 21(3):511-6. PubMed ID: 21436699
[TBL] [Abstract][Full Text] [Related]
10. Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer Database.
Seagle BL; Alexander AL; Lantsman T; Shahabi S
Am J Obstet Gynecol; 2018 Mar; 218(3):329.e1-329.e15. PubMed ID: 29223598
[TBL] [Abstract][Full Text] [Related]
11. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
[TBL] [Abstract][Full Text] [Related]
12. A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis.
Lax SF; Kurman RJ; Pizer ES; Wu L; Ronnett BM
Am J Surg Pathol; 2000 Sep; 24(9):1201-8. PubMed ID: 10976693
[TBL] [Abstract][Full Text] [Related]
13. Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.
Timmerman S; Van Rompuy AS; Van Gorp T; Vanden Bempt I; Brems H; Van Nieuwenhuysen E; Han SN; Neven P; Victoor J; Laenen A; Vergote I
Gynecol Oncol; 2020 Apr; 157(1):245-251. PubMed ID: 31980219
[TBL] [Abstract][Full Text] [Related]
14. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
[No Abstract] [Full Text] [Related]
15. Papillary serous carcinoma of the peritoneum coexisting with or after endometrial carcinoma.
Altaras MM; Bernheim J; Zehavi T; Drucker L; Uziel O; Fishman A
Gynecol Oncol; 2002 Feb; 84(2):245-51. PubMed ID: 11812082
[TBL] [Abstract][Full Text] [Related]
16. Bone metastases in endometrial cancer: report on 19 patients and review of the medical literature.
Uccella S; Morris JM; Bakkum-Gamez JN; Keeney GL; Podratz KC; Mariani A
Gynecol Oncol; 2013 Sep; 130(3):474-82. PubMed ID: 23685013
[TBL] [Abstract][Full Text] [Related]
17. [Clinical course of ovarian cancer in relation to morphologic prognostic factors and cell kinetic parameters].
Kühn W; Feichter GE; Hanke J; Rummel HH; Kaufmann M; Schmid H
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):446-51. PubMed ID: 3623047
[TBL] [Abstract][Full Text] [Related]
18. Endometrial carcinoma: clinical characteristic and survival rates by the new compared to the prior FIGO staging systems.
Tangjitgamol S; Srijaipracharoen S; Manusirivithaya S; Khunnarong J; Pataradool K; Thavaramara T
J Med Assoc Thai; 2013 May; 96(5):505-12. PubMed ID: 23745302
[TBL] [Abstract][Full Text] [Related]
19. Total Laparoscopic Hysterectomy With Percutaneous (Percuvance) Instruments: New Frontier of Minimally Invasive Gynecological Surgery.
Rossitto C; Gueli Alletti S; Costantini B; Fanfani F; Scambia G
J Minim Invasive Gynecol; 2016 Jan; 23(1):14-5. PubMed ID: 26386388
[TBL] [Abstract][Full Text] [Related]
20. Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?
Ballester M; Koskas M; Coutant C; Chéreau E; Seror J; Rouzier R; Daraï E
BMC Cancer; 2010 Aug; 10():465. PubMed ID: 20804553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
